本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Coherus Biosciences

1.33
-0.0100-0.75%
盤後1.350.0200+1.50%19:30 EDT
成交量:52.92萬
成交額:71.07萬
市值:2.05億
市盈率:-1.33
高:1.38
開:1.38
低:1.33
收:1.34
52周最高:2.62
52周最低:1.09
股本:1.54億
流通股本:1.36億
量比:0.84
換手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-1.0011
每股收益(LYR):1.43
淨資產收益率:-178.39%
總資產收益率:-30.52%
市淨率:3.37
市盈率(LYR):0.93

資料載入中...

2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/18

重要事件披露

Form 8-K - Current report
2023/05/15

重要事件披露

Form 8-K - Current report
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/06

重要事件披露

8-K - Current report
2023/03/06

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/13

重要事件披露

8-K - Current report
2022/11/15

SEC問詢函

CORRESP [Cover] - Correspondence